Gary L. Rosner - Publications

Affiliations: 
Rice University, Houston, TX 
Area:
Statistics, Biostatistics Biology

145 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Hong H, Wang C, Rosner GL. Meta-analysis of rare adverse events in randomized clinical trials: Bayesian and frequentist methods. Clinical Trials (London, England). 1740774520969136. PMID 33258698 DOI: 10.1177/1740774520969136  0.96
2020 Wang C, Wang Z, Rosner GL, Huh WK, Roden RBS, Bae S. A batch-effect adjusted Simon's two-stage design for cancer vaccine clinical studies. Biometrics. PMID 32822525 DOI: 10.1111/Biom.13358  0.96
2020 Rosner GL, Müller P. Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan. Biometrics. PMID 32251527 DOI: 10.1111/Biom.13254  0.36
2019 Wang C, Rosner GL. A Bayesian nonparametric causal inference model for synthesizing randomized clinical trial and real-world evidence. Statistics in Medicine. PMID 30883861 DOI: 10.1002/sim.8134  0.96
2018 Wang C, Rosner GL, Roden RBS. A Bayesian design for phase I cancer therapeutic vaccine trials. Statistics in Medicine. PMID 30368868 DOI: 10.1002/sim.8021  0.96
2015 Lombardi LR, Kanakry C, Zahurak M, Durakovic N, Bolaños-Meade J, Kasamon YL, Gladstone DE, Matsui W, Borrello I, Huff CA, Swinnen LJ, Brodsky RA, Ambinder RF, Fuchs EJ, Rosner GL, et al. Therapeutic drug monitoring for either oral or intravenous busulfan when combined with pre- and post-transplantation cyclophosphamide. Leukemia & Lymphoma. 1-30. PMID 26292764 DOI: 10.3109/10428194.2015.1071488  0.36
2015 Kasamon YL, Bolaños-Meade J, Prince GT, Tsai HL, McCurdy SR, Kanakry JA, Rosner GL, Brodsky RA, Perica K, Smith BD, Gladstone DE, Swinnen LJ, Showel MM, Matsui WH, Huff CA, et al. Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26261255 DOI: 10.1200/JCO.2014.60.4777  0.36
2015 Kanakry JA, Gocke CD, Bolaños-Meade J, Gladstone DE, Swinnen LJ, Blackford AL, Fuchs EJ, Huff CA, Borrello I, Matsui WH, Brodsky RA, Rosner GL, Shanbhag S, Luznik L, Jones RJ, et al. Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26183076 DOI: 10.1016/j.bbmt.2015.07.012  0.36
2015 Zeidner JF, Foster MC, Blackford AL, Litzow MR, Morris LE, Strickland SA, Lancet JE, Bose P, Levy MY, Tibes R, Gojo I, Gocke CD, Rosner GL, Little RF, Wright JJ, et al. Randomized multicenter phase 2 study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia. Haematologica. PMID 26022709 DOI: 10.3324/haematol.2015.125849  0.36
2015 Kelly RJ, Forde PM, Elnahal SM, Forastiere AA, Rosner GL, Smith TJ. Patients and Physicians Can Discuss Costs of Cancer Treatment in the Clinic. Journal of Oncology Practice / American Society of Clinical Oncology. 11: 308-12. PMID 26015459 DOI: 10.1200/JOP.2015.003780  0.36
2015 Paller CJ, Rudek MA, Zhou XC, Wagner WD, Hudson TS, Anders N, Hammers HJ, Dowling D, King S, Antonarakis ES, Drake CG, Eisenberger MA, Denmeade SR, Rosner GL, Carducci MA. A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination. The Prostate. PMID 26012728 DOI: 10.1002/Pros.23024  0.36
2015 Noonan KA, Huff CA, Davis J, Lemas MV, Fiorino S, Bitzan J, Ferguson A, Emerling A, Luznik L, Matsui W, Powell J, Fuchs E, Rosner GL, Epstein C, Rudraraju L, et al. Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma. Science Translational Medicine. 7: 288ra78. PMID 25995224 DOI: 10.1126/Scitranslmed.Aaa7014  0.36
2015 Crona DJ, Ramirez J, Qiao W, de Graan AJ, Ratain MJ, van Schaik RH, Mathijssen RH, Rosner GL, Innocenti F. Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study. The Pharmacogenomics Journal. PMID 25869015 DOI: 10.1038/tpj.2015.23  0.36
2015 McCurdy SR, Kanakry JA, Showel MM, Tsai HL, Bolaños-Meade J, Rosner GL, Kanakry CG, Perica K, Symons HJ, Brodsky RA, Gladstone DE, Huff CA, Pratz KW, Prince GT, Dezern AE, et al. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide. Blood. 125: 3024-31. PMID 25814532 DOI: 10.1182/blood-2015-01-623991  0.36
2015 Zeidner JF, Zahurak M, Rosner GL, Gocke CD, Jones RJ, Smith BD. The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions? Leukemia & Lymphoma. 56: 128-34. PMID 24712979 DOI: 10.3109/10428194.2014.910868  0.36
2014 Ivanova A, Rosner GL, Marchenko O, Parke T, Perevozskaya I, Wang Y. Advances in Statistical Approaches Oncology Drug Development. Therapeutic Innovation & Regulatory Science. 48: 81-89. PMID 25949927 DOI: 10.1177/2168479013501309  0.36
2014 Kanakry CG, Tsai HL, Bolaños-Meade J, Smith BD, Gojo I, Kanakry JA, Kasamon YL, Gladstone DE, Matsui W, Borrello I, Huff CA, Swinnen LJ, Powell JD, Pratz KW, DeZern AE, ... ... Rosner GL, et al. Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS. Blood. 124: 3817-27. PMID 25316679 DOI: 10.1182/Blood-2014-07-587477  0.36
2014 Paller CJ, Bradbury PA, Ivy SP, Seymour L, LoRusso PM, Baker L, Rubinstein L, Huang E, Collyar D, Groshen S, Reeves S, Ellis LM, Sargent DJ, Rosner GL, LeBlanc ML, et al. Design of phase I combination trials: recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4210-7. PMID 25125258 DOI: 10.1158/1078-0432.Ccr-14-0521  0.36
2014 Müller P, Quintana FA, Rosner GL, Maitland ML. Bayesian inference for longitudinal data with non-parametric treatment effects. Biostatistics (Oxford, England). 15: 341-52. PMID 24285773 DOI: 10.1093/Biostatistics/Kxt049  0.36
2014 Paller CJ, Olatoye D, Xie S, Zhou X, Denmeade SR, Eisenberger MA, Antonarakis ES, Carducci MA, Rosner GL. The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer Prostate Cancer and Prostatic Diseases. 17: 28-33. PMID 24100642 DOI: 10.1038/pcan.2013.40  0.36
2014 Wu D, Kafadar K, Rosner GL. Inference of long term effects and overdiagnosis in periodic cancer screening Statistica Sinica. 24: 815-831. DOI: 10.5705/Ss.2012.067  0.36
2013 Cruz-Marcelo A, Rosner GL, Müller P, Stewart CF. Effect on Prediction when Modeling Covariates in Bayesian Nonparametric Models. Journal of Statistical Theory and Practice. 7: 204-218. PMID 23687472 DOI: 10.1080/15598608.2013.772811  0.36
2013 Holdhoff M, Rosner GL, Alcorn S, Grossman SA. 'Elderly' patients with newly diagnosed glioblastoma deserve optimal care. Journal of Neuro-Oncology. 113: 343-4. PMID 23526408 DOI: 10.1007/s11060-013-1113-7  0.36
2013 Qin L, Smith BD, Tsai HL, Yaghi NK, Neela PH, Moake M, Fu J, Kasamon YL, Prince GT, Goswami M, Rosner GL, Levitsky HI, Hourigan CS. Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy Blood Cancer Journal. 3. DOI: 10.1038/bcj.2013.44  0.36
2012 Karrison TG, Ratain MJ, Stadler WM, Rosner GL. Estimation of Progression-Free Survival for All Treated Patients in the Randomized Discontinuation Trial Design. The American Statistician. 66: 155-162. PMID 24039273 DOI: 10.1080/00031305.2012.720900  0.36
2012 Wu D, Kafadar K, Rosner GL, Broemeling LD. The lead time distribution when lifetime is subject to competing risks in cancer screening. The International Journal of Biostatistics. 8. PMID 22611589 DOI: 10.1515/1557-4679.1363  0.36
2012 Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 1553-61. PMID 22473167 DOI: 10.1200/JCO.2011.39.9436  0.36
2012 Ramsey LB, Bruun GH, Yang W, Treviño LR, Vattathil S, Scheet P, Cheng C, Rosner GL, Giacomini KM, Fan Y, Sparreboom A, Mikkelsen TS, Corydon TJ, Pui CH, Evans WE, et al. Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition. Genome Research. 22: 1-8. PMID 22147369 DOI: 10.1101/Gr.129668.111  0.36
2012 Trippa L, Rosner GL, Müller P. Bayesian enrichment strategies for randomized discontinuation trials. Biometrics. 68: 203-11. PMID 21714780 DOI: 10.1111/J.1541-0420.2011.01623.X  0.36
2011 Cruz-Marcelo A, Ensor KB, Rosner GL. Estimating the Term Structure With a Semiparametric Bayesian Hierarchical Model: An Application to Corporate Bonds. Journal of the American Statistical Association. 106: 387-395. PMID 21765566 DOI: 10.1198/Jasa.2011.Ap09764  0.36
2011 Müller P, Quintana F, Rosner GL. A Product Partition Model With Regression on Covariates. Journal of Computational and Graphical Statistics : a Joint Publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America. 20: 260-278. PMID 21566678 DOI: 10.1198/Jcgs.2011.09066  0.36
2011 Chen MY, Liao WS, Lu Z, Bornmann WG, Hennessey V, Washington MN, Rosner GL, Yu Y, Ahmed AA, Bast RC. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy. Cancer. 117: 4424-38. PMID 21491416 DOI: 10.1002/Cncr.26073  0.36
2011 Wu D, Erwin D, Rosner GL. Sojourn time and lead time projection in lung cancer screening. Lung Cancer (Amsterdam, Netherlands). 72: 322-6. PMID 21075475 DOI: 10.1016/J.Lungcan.2010.10.010  0.36
2011 Trippa L, Rosner GL, Muller P. Rejoinder Biometrics. DOI: 10.1111/j.1541-0420.2011.01628.x  0.36
2011 Jara A, Hanson TE, Quintana FA, Müller P, Rosner GL. DPpackage: Bayesian semi- and nonparametric modeling in R Journal of Statistical Software. 40: 1-30.  0.36
2010 Yang Y, Müller P, Rosner GL. Semiparametric Bayesian inference for repeated fractional measurement data. Chilean Journal of Statistics. 1: 59-74. PMID 21822354  0.36
2010 Erb TO, von Ungern-Sternberg BS, Keller K, Rosner GL, Craig D, Frei FJ. Fentanyl does not reduce the incidence of laryngospasm in children anesthetized with sevoflurane. Anesthesiology. 113: 41-7. PMID 20508496 DOI: 10.1097/ALN.0b013e3181dcd875  0.36
2010 Hennessey VG, Rosner GL, Bast RC, Chen MY. A Bayesian approach to dose-response assessment and synergy and its application to in vitro dose-response studies. Biometrics. 66: 1275-83. PMID 20337630 DOI: 10.1111/J.1541-0420.2010.01403.X  0.36
2010 Steinberg MJ, Rubin ER. Commentary: Compliance education and training: a need for new responses in clinical research. Academic Medicine : Journal of the Association of American Medical Colleges. 85: 395-7. PMID 20182108 DOI: 10.1097/ACM.0b013e3181cccbed  0.36
2009 Wu D, Erwin D, Rosner GL. A projection of benefits due to fecal occult blood test for colorectal cancer. Cancer Epidemiology. 33: 212-5. PMID 19733140 DOI: 10.1016/J.Canep.2009.08.001  0.36
2009 Hoskins JM, Rosner GL, Ratain MJ, McLeod HL, Innocenti F. Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan. Pharmacogenomics. 10: 1139-46. PMID 19604089 DOI: 10.2217/Pgs.09.35  0.36
2009 Gu X, Frankowski RF, Rosner GL, Relling M, Peng B, Amos CI. A modified forward multiple regression in high-density genome-wide association studies for complex traits. Genetic Epidemiology. 33: 518-25. PMID 19365845 DOI: 10.1002/Gepi.20404  0.36
2009 Innocenti F, Kroetz DL, Schuetz E, Dolan ME, Ramírez J, Relling M, Chen P, Das S, Rosner GL, Ratain MJ. Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2604-14. PMID 19349540 DOI: 10.1200/Jco.2008.20.6300  0.36
2009 De Iorio M, Johnson WO, Müller P, Rosner GL. Bayesian nonparametric nonproportional hazards survival modeling. Biometrics. 65: 762-71. PMID 19210742 DOI: 10.1111/J.1541-0420.2008.01166.X  0.36
2009 Yang H, Kadia T, Xiao L, Bueso-Ramos CE, Hoshino K, Thomas DA, O'Brien S, Jabbour E, Pierce S, Rosner GL, Kantarjian HM, Garcia-Manero G. Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia. Blood. 113: 1892-8. PMID 19109226 DOI: 10.1182/Blood-2008-02-141002  0.36
2009 Thompson PA, Rosner GL, Matthay KK, Moore TB, Bomgaars LR, Ellis KJ, Renbarger J, Berg SL. Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study. Cancer Chemotherapy and Pharmacology. 64: 243-51. PMID 19020877 DOI: 10.1007/S00280-008-0854-Z  0.36
2009 Wu D, Erwin D, Rosner GL. Estimating key parameters in FOBT screening for colorectal cancer. Cancer Causes & Control : Ccc. 20: 41-6. PMID 18704710 DOI: 10.1007/S10552-008-9215-9  0.36
2009 Innocenti F, Mirkov S, Nagasubramanian R, Ramírez J, Liu W, Bleibel WK, Shukla SJ, Hennessy K, Rosner GL, Cook E, Eileen Dolan M, Ratain MJ. The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds. Cancer Chemotherapy and Pharmacology. 63: 881-7. PMID 18677484 DOI: 10.1007/S00280-008-0793-8  0.36
2008 Quintana FA, Müler P, Rosner GL, Munsell M. Semi-parametric Bayesian Inference for Multi-Season Baseball Data. Bayesian Analysis (Online). 3: 317-338. PMID 21909346 DOI: 10.1214/08-Ba312  0.36
2008 Quintana FA, Müller P, Rosner GL, Relling MV. A Semiparametric Bayesian Model for Repeatedly Repeated Binary Outcomes. Journal of the Royal Statistical Society. Series C, Applied Statistics. 57: 419-431. PMID 19746193 DOI: 10.1111/J.1467-9876.2008.00619.X  0.36
2008 Rosner GL, Panetta JC, Innocenti F, Ratain MJ. Pharmacogenetic pathway analysis of irinotecan Clinical Pharmacology and Therapeutics. 84: 393-402. PMID 18418374 DOI: 10.1038/Clpt.2008.63  0.36
2008 Thompson PA, Gupta M, Rosner GL, Yu A, Barrett J, Bomgaars L, Bernstein ML, Blaney SM, Mondick J. Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group. Cancer Chemotherapy and Pharmacology. 62: 1027-37. PMID 18278496 DOI: 10.1007/S00280-008-0692-Z  0.36
2008 Davies SM, Borowitz MJ, Rosner GL, Ritz K, Devidas M, Winick N, Martin PL, Bowman P, Elliott J, Willman C, Das S, Cook EH, Relling MV. Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 111: 2984-90. PMID 18182569 DOI: 10.1182/Blood-2007-09-114082  0.36
2008 Ding M, Rosner GL, Müller P. Bayesian optimal design for phase II screening trials. Biometrics. 64: 886-94. PMID 18162113 DOI: 10.1111/J.1541-0420.2007.00951.X  0.36
2008 Garcia-Manero G, Yang H, Bueso-Ramos C, Ferrajoli A, Cortes J, Wierda WG, Faderl S, Koller C, Morris G, Rosner G, Loboda A, Fantin VR, Randolph SS, Hardwick JS, Reilly JF, et al. Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes. Blood. 111: 1060-6. PMID 17962510 DOI: 10.1182/Blood-2007-06-098061  0.36
2008 Müller P, Rosner GL. Discussion of "Simple, Defensible Sample Sizes Based on Cost Efficiency," by P. Bacchetti, C. E. McCulloch, and M. R. Segal Biometrics. DOI: 10.1111/J.1541-0420.2008.01006.X  0.36
2008 Müller P, Rosner GL. Discussions Biometrics. 64: 587-589. DOI: 10.1111/j.1541-0420.2008.01004_3.x  0.36
2007 Wu D, Rosner GL, Broemeling LD. Bayesian inference for the lead time in periodic cancer screening. Biometrics. 63: 873-80. PMID 17825017 DOI: 10.1111/J.1541-0420.2006.00732.X  0.36
2007 Lewis LD, Miller AA, Rosner GL, Dowell JE, Valdivieso M, Relling MV, Egorin MJ, Bies RR, Hollis DR, Levine EG, Otterson GA, Millard F, Ratain MJ. A comparison of the pharmacokinetics and pharmacodynamics of docetaxel between African-American and Caucasian cancer patients: CALGB 9871. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3302-11. PMID 17545536 DOI: 10.1158/1078-0432.Ccr-06-2345  0.36
2007 Müller P, Quintana FA, Rosner GL. Semiparametric bayesian inference for multilevel repeated measurement data. Biometrics. 63: 280-9. PMID 17447954 DOI: 10.1111/J.1541-0420.2006.00668.X  0.36
2007 Kishi S, Cheng C, French D, Pei D, Das S, Cook EH, Hijiya N, Rizzari C, Rosner GL, Frudakis T, Pui CH, Evans WE, Relling MV. Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood. 109: 4151-7. PMID 17264302 DOI: 10.1182/Blood-2006-10-054528  0.36
2007 Thompson PA, Murry DJ, Rosner GL, Lunagomez S, Blaney SM, Berg SL, Camitta BM, Dreyer ZE, Bomgaars LR. Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology. 59: 847-53. PMID 17136402 DOI: 10.1007/S00280-006-0388-1  0.36
2007 Rossell D, Müller P, Rosner GL. Screening designs for drug development. Biostatistics (Oxford, England). 8: 595-608. PMID 17030589 DOI: 10.1093/Biostatistics/Kxl031  0.36
2007 Ghosh P, Rosner GL. A semi-parametric Bayesian approach to average bioequivalence. Statistics in Medicine. 26: 1224-36. PMID 16832840 DOI: 10.1002/Sim.2620  0.36
2006 Ratain MJ, Eisen T, Stadler WM, Flaherty KT, Kaye SB, Rosner GL, Gore M, Desai AA, Patnaik A, Xiong HQ, Rowinsky E, Abbruzzese JL, Xia C, Simantov R, Schwartz B, et al. Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2505-12. PMID 16636341 DOI: 10.1200/Jco.2005.03.6723  0.36
2006 Lichtman SM, Hollis D, Miller AA, Rosner GL, Rhoades CA, Lester EP, Millard F, Byrd J, Cullinan SA, Rosen DM, Parise RA, Ratain MJ, Egorin MJ. Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 1846-51. PMID 16567769 DOI: 10.1200/Jco.2005.03.9289  0.36
2006 Klein CE, Kastrissios H, Miller AA, Hollis D, Yu D, Rosner GL, Grinblatt DL, Larson RA, Ratain MJ. Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study. Cancer Chemotherapy and Pharmacology. 57: 199-206. PMID 16158312 DOI: 10.1007/S00280-005-0023-6  0.36
2005 Wu D, Rosner GL, Broemeling L. MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screening. Biometrics. 61: 1056-63. PMID 16401279 DOI: 10.1111/J.1541-0420.2005.00361.X  0.36
2005 Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR, Issa JP. MGMT promoter methylation and field defect in sporadic colorectal cancer. Journal of the National Cancer Institute. 97: 1330-8. PMID 16174854 DOI: 10.1093/Jnci/Dji275  0.36
2005 Thrall DE, LaRue SM, Yu D, Samulski T, Sanders L, Case B, Rosner G, Azuma C, Poulson J, Pruitt AF, Stanley W, Hauck ML, Williams L, Hess P, Dewhirst MW. Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5206-14. PMID 16033838 DOI: 10.1158/1078-0432.Ccr-05-0091  0.36
2005 Peters WP, Rosner GL, Vredenburgh JJ, Shpall EJ, Crump M, Richardson PG, Schuster MW, Marks LB, Cirrincione C, Norton L, Henderson IC, Schilsky RL, Hurd DD. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2191-200. PMID 15767638 DOI: 10.1200/Jco.2005.10.202  0.36
2005 Rosner GL. Bayesian monitoring of clinical trials with failure-time endpoints. Biometrics. 61: 239-45. PMID 15737099 DOI: 10.1111/J.0006-341X.2005.031037.X  0.36
2005 Müller P, Rosner GL, De Iorio M, MacEachern S. A nonparametric Bayesian model for inference in related longitudinal studies Journal of the Royal Statistical Society. Series C: Applied Statistics. 54: 611-626. DOI: 10.1111/J.1467-9876.2005.05475.X  0.36
2004 Miller AA, Rosner GL, Egorin MJ, Hollis D, Lichtman SM, Ratain MJ. Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and Leukemia Group B Study 9763. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 8325-31. PMID 15623609 DOI: 10.1158/1078-0432.Ccr-04-1078  0.36
2004 Wu MH, Chen P, Wu X, Liu W, Strom S, Das S, Cook EH, Rosner GL, Dolan ME. Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 gene. Pharmacogenetics. 14: 595-605. PMID 15475733 DOI: 10.1097/00008571-200409000-00004  0.36
2004 Relling MV, Yang W, Das S, Cook EH, Rosner GL, Neel M, Howard S, Ribeiro R, Sandlund JT, Pui CH, Kaste SC. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 3930-6. PMID 15459215 DOI: 10.1200/Jco.2004.11.020  0.36
2004 Schuetz EG, Relling MV, Kishi S, Yang W, Das S, Chen P, Cook EH, Rosner GL, Pui CH, Blanco JG, Edick MJ, Hancock ML, Winick NJ, Dervieux T, Amylon MD, et al. PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5. Pharmacological Reviews. 56: 159. PMID 15169924 DOI: 10.1124/Pr.56.2.1  0.36
2004 Kishi S, Yang W, Boureau B, Morand S, Das S, Chen P, Cook EH, Rosner GL, Schuetz E, Pui CH, Relling MV. Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. Blood. 103: 67-72. PMID 12969965 DOI: 10.1182/Blood-2003-06-2105  0.36
2004 De Iorio M, Müller P, Rosner GL, MacEachern SN. An ANOVA Model for Dependent Random Measures Journal of the American Statistical Association. 99: 205-215. DOI: 10.1198/016214504000000205  0.36
2003 Venook AP, Klein CE, Fleming G, Hollis D, Leichman CG, Hohl R, Byrd J, Budman D, Villalona M, Marshall J, Rosner GL, Ramirez J, Kastrissios H, Ratain MJ. A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863 Annals of Oncology. 14: 1783-1790. PMID 14630685 DOI: 10.1093/Annonc/Mdg493  0.36
2003 Lopes HF, Müller P, Rosner GL. Bayesian meta-analysis for longitudinal data models using multivariate mixture priors. Biometrics. 59: 66-75. PMID 12762442 DOI: 10.1111/1541-0420.00008  0.36
2003 Rizzieri DA, Ibom VK, Moore JO, DeCastro CM, Rosner GL, Adams DJ, Foster T, Payne N, Thompson M, Vredenburgh JJ, Gasparetto C, Long GD, Chao NJ, Gockerman JP. Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 663-8. PMID 12576433  0.36
2002 Fleming GF, Meropol NJ, Rosner GL, Hollis DR, Carson WE, Caligiuri M, Mortimer J, Tkaczuk K, Parihar R, Schilsky RL, Ratain MJ. A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 3718-27. PMID 12473581  0.36
2002 Rosner GL, Stadler W, Ratain MJ. Randomized discontinuation design: application to cytostatic antineoplastic agents. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 4478-84. PMID 12431972 DOI: 10.1200/Jco.2002.11.126  0.36
2002 Bass AJ, Gockerman JP, Hammett E, DeCastro CM, Adams DJ, Rosner GL, Payne N, Davis P, Foster T, Moore JO, Rizzieri DA. Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 2995-3000. PMID 12089230 DOI: 10.1200/Jco.2002.08.166  0.36
2002 Rizzieri DA, Bass AJ, Rosner GL, Gockerman JP, DeCastro CM, Petros WP, Adams DJ, Laughlin MJ, Davis P, Foster T, Jacobson R, Hurwitz H, Moore JO. Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 674-9. PMID 11821447 DOI: 10.1200/Jco.20.3.674  0.36
2001 Snyder SA, Lanzen JL, Braun RD, Rosner G, Secomb TW, Biaglow J, Brizel DM, Dewhirst MW. Simultaneous administration of glucose and hyperoxic gas achieves greater improvement in tumor oxygenation than hyperoxic gas alone International Journal of Radiation Oncology Biology Physics. 51: 494-506. PMID 11567826 DOI: 10.1016/S0360-3016(01)01654-6  0.36
2001 Maguire PD, Samulski TV, Prosnitz LR, Jones EL, Rosner GL, Powers B, Layfield LW, Brizel DM, Scully SP, Harrelson JM, Dewhirst MW. A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 17: 283-90. PMID 11471980 DOI: 10.1080/02656730110039449  0.36
2001 Gandhi V, Plunkett W, Weller S, Du M, Ayres M, Rodriguez C.O. J, Ramakrishna P, Rosner GL, Hodge JP, O'Brien S, Keating MJ. Evaluation of the combination of nelarabine and fludarabine in leukemias: Clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells Journal of Clinical Oncology. 19: 2142-2152. PMID 11304766 DOI: 10.1200/Jco.2001.19.8.2142  0.36
2001 Müller P, Rosner GL, Inoue LYT, Dewhirst MW. A Bayesian Model for Detecting Acute Change in Nonlinear Profiles Journal of the American Statistical Association. 96: 1215-1222. DOI: 10.1198/016214501753381869  0.36
2001 Stroud JR, Müller P, Rosner GL. Optimal sampling times in population pharmacokinetic studies Journal of the Royal Statistical Society Series C-Applied Statistics. 50: 345-359. DOI: 10.1111/1467-9876.00239  0.36
2001 Stroud JR, Müller P, Rosner GL. Optimal sampling times in population pharmacokinetic studies Journal of the Royal Statistical Society. Series C: Applied Statistics. 50: 345-359.  0.36
2001 Müller P, Rosner GL, Inoue LYT, Dewhirst MW. A Bayesian Model for Detecting Acute Change in Nonlinear Profiles Journal of the American Statistical Association. 96: 1215-1222.  0.36
2000 Thrall DE, Rosner GL, Azuma C, Larue SM, Case BC, Samulski T, Dewhirst MW. Using units of CEM 43 degrees C T90, local hyperthermia thermal dose can be delivered as prescribed. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 16: 415-28. PMID 11001575 DOI: 10.1080/026567300416712  0.36
2000 Meyer RE, Braun RD, Rosner GL, Dewhirst MW. Local 42°C hyperthermia improves vascular conductance of the R3230Ac rat mammary adenocarcinoma during sodium nitroprusside infusion Radiation Research. 154: 196-201. PMID 10931692 DOI: 10.1667/0033-7587(2000)154[0196:Lchivc]2.0.Co;2  0.36
2000 Venook AP, Egorin MJ, Rosner GL, Hollis D, Mani S, Hawkins M, Byrd J, Hohl R, Budman D, Meropol NJ, Ratain MJ. Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and leukemia group B 9565 Journal of Clinical Oncology. 18: 2780-2787. PMID 10894879 DOI: 10.1200/Jco.2000.18.14.2780  0.36
1999 Prosnitz LR, Maguire P, Anderson JM, Scully SP, Harrelson JM, Jones EL, Dewhirst M, Samulski TV, Powers BE, Rosner GL, Dodge RK, Layfield L, Clough R, Brizel DM. The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy. International Journal of Radiation Oncology, Biology, Physics. 45: 941-9. PMID 10571201 DOI: 10.1016/S0360-3016(99)00272-2  0.36
1999 Dunn TJ, Braun RD, Rhemus WE, Rosner GL, Secomb TW, Tozer GM, Chaplin DJ, Dewhirst MW. The effects of hyperoxic and hypercarbic gases on tumour blood flow. British Journal of Cancer. 80: 117-26. PMID 10389987 DOI: 10.1038/Sj.Bjc.6690330  0.36
1998 Lilenbaum RC, Miller AA, Batist G, Bernard S, Hollis DR, Rosner GL, Egorin MJ, Schilsky RL, Ratain MJ. Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: A cancer and leukemia group B study Journal of Clinical Oncology. 16: 3302-3309. PMID 9779705 DOI: 10.1200/Jco.1998.16.10.3302  0.36
1998 Venook AP, Egorin MJ, Rosner GL, Brown TD, Jahan TM, Batist G, Hohl R, Budman D, Ratain MJ, Kearns CM, Schilsky RL. Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and leukemia group B 9264 Journal of Clinical Oncology. 16: 1811-1819. PMID 9586895 DOI: 10.1200/Jco.1998.16.5.1811  0.36
1998 Acker JC, Marks LB, Spencer DP, Yang W, Avery MA, Dodge RK, Rosner GL, Dewhirst MW. Serial in vivo observations of cerebral vasculature after treatment with a large single fraction of radiation. Radiation Research. 149: 350-9. PMID 9525499 DOI: 10.2307/3579697  0.36
1997 Miller AA, Rosner GL, Ratain MJ, Hollis DR, Green MR, Schilsky RL. Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: A cancer and leukemia group B study (CALGB 9062) Clinical Cancer Research. 3: 719-725. PMID 9815741  0.36
1997 Samuels BL, Hollis DR, Rosner GL, Trump DL, Shapiro CL, Vogelzang NJ, Schilsky RL. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 3: 1977-84. PMID 9815587  0.36
1997 Rosner GL, Müller P. Bayesian population pharmacokinetic and pharmacodynamic analyses using mixture models Journal of Pharmacokinetics and Biopharmaceutics. 25: 209-233. PMID 9408860 DOI: 10.1023/A:1025784113869  0.36
1997 Thrall DE, Rosner GL, Azuma C, McEntee MC, Raleigh JA. Hypoxia marker labeling in tumor biopsies: quantification of labeling variation and criteria for biopsy sectioning. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 44: 171-6. PMID 9288846 DOI: 10.1016/S0167-8140(97)01931-2  0.36
1997 Shan SQ, Rosner GL, Braun RD, Hahn J, Pearce C, Dewhirst MW. Effects of diethylamine/nitric oxide on blood perfusion and oxygenation in the R3230Ac mammary carcinoma British Journal of Cancer. 76: 429-437. PMID 9275018 DOI: 10.1038/Bjc.1997.406  0.36
1997 Cline JM, Rosner GL, Raleigh JA, Thrall DE. Quantification of CCI-103F labeling heterogeneity in canine solid tumors International Journal of Radiation Oncology Biology Physics. 37: 655-662. PMID 9112464 DOI: 10.1016/S0360-3016(96)00559-7  0.36
1997 Hahn JS, Braun RD, Dewhirst MW, Shan S, Snyder SA, Taube JM, Ong ET, Rosner GL, Dodge RK, Bonaventura J, Bonaventura C, Deangelo J, Meyer RE. Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure Radiation Research. 147: 185-194. PMID 9008211 DOI: 10.2307/3579420  0.36
1997 Müller P, Rosner GL. A Bayesian Population Model with Hierarchical Mixture Priors Applied to Blood Count Data Journal of the American Statistical Association. 92: 1279-1292. DOI: 10.1080/01621459.1997.10473649  0.36
1997 Müller P, Rosner GL. A Bayesian population model with hierarchical mixture priors applied to blood count data Journal of the American Statistical Association. 92: 1279-1292.  0.36
1996 Rosner GL, Clegg ST, Prescott DM, Dewhirst MW. Estimation of cell survival in tumours heated to nonuniform temperature distributions. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 12: 303-4. PMID 8926397  0.36
1996 Rosner GL, Clegg ST, Prescott DM, Dewhirst MW. Estimation of cell survival in tumours heated to nonuniform temperature distributions. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 12: 223-39. PMID 8926391 DOI: 10.3109/02656739609022511  0.36
1996 Rosner GL, Hargis JB, Hollis DR, Budman DR, Weiss RB, Henderson IC, Schilsky RL. Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: Results from Cancer and Leukemia Group B study 8541 Journal of Clinical Oncology. 14: 3000-3008. PMID 8918498  0.36
1996 Petros WP, Rosner GL, Rabinowitz J, Gilbert CJ, Coniglio D, Vredenburgh JJ, Ross M, Peters WP. The pharmacologic effects of recombinant, human colony-stimulating factors and their modulation by theophylline. Pharmacotherapy. 16: 742-8. PMID 8888069 DOI: 10.1002/J.1875-9114.1996.Tb02991.X  0.36
1996 Dewhirst MW, Ong ET, Rosner GL, Rehmus SW, Shan S, Braun RD, Brizel DM, Secomb TW. Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content The British Journal of Cancer. Supplement. 27: S241-246. PMID 8763889  0.36
1996 Miller AA, Lilenbaum RC, Lynch TJ, Rosner GL, Ratain MJ, Green MR, Schilsky RL. Treatment-related fatal sepsis from topotecan/cisplatin and topotecan/paclitaxel [1] Journal of Clinical Oncology. 14: 1964. PMID 8656268 DOI: 10.1200/Jco.1996.14.6.1964  0.36
1996 Thrall DE, Prescott DM, Samulski TV, Rosner GL, Denman DL, Legorreta RL, Dodge RK, Page RL, Cline JM, Lee J, Case BC, Evans SM, Oleson JR, Dewhirst MW. Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomas. International Journal of Radiation Oncology, Biology, Physics. 34: 1087-96. PMID 8600092 DOI: 10.1016/0360-3016(95)02260-0  0.36
1995 Rosner GL, Berry DA. A Bayesian group sequential design for a multiple arm randomized clinical trial Statistics in Medicine. 14: 381-394. PMID 7746978 DOI: 10.1002/Sim.4780140405  0.36
1995 Fleming RA, Capizzi RL, Rosner GL, Oliver LK, Smith SJ, Schiffer CA, Silver RT, Peterson BA, Weiss RB, Omura GA. Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B study. Cancer Chemotherapy and Pharmacology. 36: 425-30. PMID 7634384 DOI: 10.1007/Bf00686192  0.36
1995 Brizel DM, Rosner GL, Prosnitz LR, Dewhirst MW. Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases International Journal of Radiation Oncology, Biology, Physics. 32: 1121-1125. PMID 7607933 DOI: 10.1016/0360-3016(95)00106-9  0.36
1995 Cartee L, Petros WP, Rosner GL, Gilbert C, Moore S, Affronti ML, Hoke JA, Hussein AM, Ross M, Rubin P, Vredenburgh JJ, Peters WP. Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study Cytokine. 7: 471-477. PMID 7578986 DOI: 10.1006/Cyto.1995.0064  0.36
1995 Lilenbaum RC, Ratain MJ, Miller AA, Hargis JB, Hollis DR, Rosner GL, O'Brien SM, Brewster L, Green MR, Schilsky RL. Phase I study of paclitaxel and topotecan in patients with advanced tumors: A cancer and leukemia group B study Journal of Clinical Oncology. 13: 2230-2237. PMID 7545219 DOI: 10.1200/Jco.1995.13.9.2230  0.36
1994 DiPietro L, Ostfeld AM, Rosner GL. Adiposity and stroke among older adults of low socioeconomic status: The Chicago Stroke Study American Journal of Public Health. 84: 14-19. PMID 8279605 DOI: 10.2105/Ajph.84.1.14  0.36
1994 Cline JM, Thrall DE, Rosner GL, Raleigh JA. Distribution of the hypoxia marker CCI-103F in canine tumors International Journal of Radiation Oncology, Biology, Physics. 28: 921-933. PMID 8138446 DOI: 10.1016/0360-3016(94)90113-9  0.36
1994 Clegg ST, Samulski TV, Murphy KA, Rosner GL, Dewhirst MW. Inverse techniques in hyperthermia: a sensitivity study. Ieee Transactions On Bio-Medical Engineering. 41: 373-82. PMID 8063303 DOI: 10.1109/10.284965  0.36
1994 Marks LB, Rosner GL, Prosnitz LR, Ross M, Vredenburgh JJ, Peters WP. The impact of conventional plus high dose chemotherapy with autologous bone marrow transplantation on hematologic toxicity during subsequent local- regional radiotherapy for breast cancer Cancer. 74: 2964-2971. PMID 7954260 DOI: 10.1002/1097-0142(19941201)74:11<2964::Aid-Cncr2820741112>3.0.Co;2-X  0.36
1994 Brizel DM, Rosner GL, Harrelson J, Prosnitz LR, Dewhirst MW. Pretreatment oxygenation profiles of human soft tissue sarcomas International Journal of Radiation Oncology, Biology, Physics. 30: 635-642. PMID 7928495 DOI: 10.1016/0360-3016(92)90950-M  0.36
1994 Miller AA, Hargis JB, Lilenbaum RC, Fields SZ, Rosner GL, Schilsky RL. Phase I study of topotecan and cisplatin in patients with advanced solid tumors: A cancer and leukemia group B study Journal of Clinical Oncology. 12: 2743-2750. PMID 7527456 DOI: 10.1200/Jco.1994.12.12.2743  0.36
1994 Rosner GL, Müller P. Pharmacodynamic analysis of hematologic profiles Journal of Pharmacokinetics and Biopharmaceutics. 22: 499-524. PMID 7473079 DOI: 10.1007/Bf02353792  0.36
1993 Brizel DM, Klitzman B, Cook JM, Edwards J, Rosner G, Dewhirst MW. A comparison of tumor and normal tissue microvascular hematocrits and red cell fluxes in a rat window chamber model International Journal of Radiation Oncology, Biology, Physics. 25: 269-276. PMID 8420874 DOI: 10.1016/0360-3016(93)90348-Y  0.36
1993 Wu NZ, Klitzman B, Rosner G, Needham D, Dewhirst MW. Measurement of Material Extravasation in Microvascular Networks Using Fluorescence Video-Microscopy Microvascular Research. 46: 231-253. PMID 8246821 DOI: 10.1006/Mvre.1993.1049  0.36
1992 Marks LB, Halperin EC, Prosnitz LR, Ross M, Vredenburgh JJ, Rosner GL, Peters W. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with ≥ 10 positive axillary lymph nodes International Journal of Radiation Oncology, Biology, Physics. 23: 1021-1026. PMID 1639635 DOI: 10.1016/0360-3016(92)90908-Z  0.36
1992 Gillette SM, Dewhirst MW, Gillette EL, Thrall DE, Page RL, Powers BE, Withrow SJ, Rosner G, Wong C, Sim DA. Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia: a randomized phase II study. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 8: 309-20. PMID 1607736 DOI: 10.3109/02656739209021786  0.36
1992 Dewhirst MW, Vinuya RZ, Ong ET, Klitzman B, Rosner G, Secomb TW, Gross JF. Effects of bradykinin on the hemodynamics of tumor and granulating normal tissue microvasculature Radiation Research. 130: 345-354. PMID 1594761 DOI: 10.2307/3578380  0.36
1992 Page RL, Macy DW, Ogilvie GK, Rosner GL, Dewhirst MW, Thrall DE, Withrow SJ, Mcentee MC, Cline JM, Heidner GL, Novotney CA, Gillette EL. Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma International Journal of Hyperthermia. 8: 187-197. PMID 1573308 DOI: 10.3109/02656739209021774  0.36
1992 Perfect JR, Klotman ME, Gilbert CC, Crawford DD, Rosner GL, Wright KA, Peters WP. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. The Journal of Infectious Diseases. 165: 891-7. PMID 1569339 DOI: 10.1093/Infdis/165.5.891  0.36
1992 Penta JS, Rosner GL, Trump DL. Choice of starting dose and escalation for phase I studies of antitumor agents Cancer Chemotherapy and Pharmacology. 31: 247-250. PMID 1464163 DOI: 10.1007/Bf00685555  0.36
1992 Dewhirst MW, Ong ET, Madwed D, Klitzman B, Secomb T, Brizel D, Bonaventura J, Rosner G, Kavanagh B, Edwards J, Gross J. Effects of the calcium channel blocker flunarizine on the hemodynamics and oxygenation of tumor microvasculature Radiation Research. 132: 61-68. PMID 1410275 DOI: 10.2307/3578334  0.36
1991 Shpall EJ, Jones RB, Bast RC, Rosner GL, Vandermark R, Ross M, Affronti ML, Johnston C, Eggteston S, Tepperburg M, Coniglio D, Peters WP. 4-hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: A phase I trial Journal of Clinical Oncology. 9: 85-93. PMID 1985173 DOI: 10.1200/Jco.1991.9.1.85  0.36
1991 Keane TE, Rosner GL, Gingrich JR, Poulton SH, Walther PJ. The therapeutic impact of dipyridamole: chemopotentiation of the cytotoxic combination 5-fluorouracil/cisplatin in an animal model of human bladder cancer. The Journal of Urology. 146: 1418-24. PMID 1942313 DOI: 10.1016/S0022-5347(17)38127-2  0.36
1990 Dewhirst MW, Prescott DM, Clegg S, Samulski TV, Page RL, Thrall DE, Leopold K, Rosner G, Acker JC, Oleson JR. The use of hydralazine to manipulate tumour temperatures during hyperthermia. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 6: 971-83. PMID 2286795 DOI: 10.3109/02656739009140980  0.36
1989 Rosner GL, Tsiatis AA. The impact that group sequential tests would have made on ECOG clinical trials Statistics in Medicine. 8: 505-516. PMID 2657957 DOI: 10.1002/Sim.4780080413  0.36
1988 Rosner GL, Tsiatis AA. Exact confidence intervals following a group sequential trial: A comparison of methods Biometrika. 75: 723-729. DOI: 10.1093/biomet/75.4.723  0.36
1985 Tsiatis AA, Rosner GL, Tritchler DL. Group sequential tests with censored survival data adjusting for covariates Biometrika. 72: 365-373. DOI: 10.1093/biomet/72.2.365  0.36
1984 Tsiatis AA, Rosner GL, Mehta CR. Exact confidence intervals following a group sequential test Biometrics. 40: 797-803. PMID 6518248 DOI: 10.2307/2530924  0.36
Show low-probability matches.